105 related articles for article (PubMed ID: 6368517)
1. Therapeutic effect of cefotetan in an experimental local infection with facultative and obligate anaerobes in granuloma pouches in rats.
Saito M; Saito T; Yano K; Shibata K; Nishino T; Tanino T
J Antimicrob Chemother; 1984 Feb; 13(2):133-42. PubMed ID: 6368517
[TBL] [Abstract][Full Text] [Related]
2. Use of cephalosporins for prophylaxis and therapy of polymicrobial infection in mice.
Brook I
Antimicrob Agents Chemother; 1993 Jul; 37(7):1531-5. PubMed ID: 8363386
[TBL] [Abstract][Full Text] [Related]
3. [In vitro and in vivo antimicrobial activities of cefmetazole against Bacteroides fragilis].
Isono M; Kawashima K; Yamada N; Aoki M; Kobayashi T; Sawa K; Watanabe K; Ueno K
Jpn J Antibiot; 1982 Jul; 35(7):1667-72. PubMed ID: 6757469
[TBL] [Abstract][Full Text] [Related]
4. [Morphological alterations in Escherichia coli and Serratia marcescens induced by cefotetan (author's transl)].
Saito M; Saito T; Yano K
Jpn J Antibiot; 1982 Mar; 35(3):850-5. PubMed ID: 7047794
[TBL] [Abstract][Full Text] [Related]
5. Prophylaxis of and therapy for polymicrobial infection in mice with cefoxitin, cefotetan, and cefmetazole.
Brook I
Clin Infect Dis; 1993 Jun; 16 Suppl 4():S425-6. PubMed ID: 8324161
[No Abstract] [Full Text] [Related]
6. beta-Lactamase produced by a highly beta-lactam-resistant strain of Bacteroides fragilis: an obstacle to the chemotherapy of experimental mixed infections.
Ajiki Y; Koga T; Ohya S; Takenouchi T; Yasuda H; Watanabe K; Ueno K
J Antimicrob Chemother; 1991 Oct; 28(4):537-46. PubMed ID: 1761449
[TBL] [Abstract][Full Text] [Related]
7. [Activity of cefotetan against anaerobic bacteria].
Sedallian A
Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):643-4. PubMed ID: 2877431
[TBL] [Abstract][Full Text] [Related]
8. [Cefotetan, a new cephamycin antibiotic: in vitro and in vivo antibacterial activities (author's transl)].
Yano K; Suzaki K; Saito M; Toda M; Naito S; Ohmi Y
Jpn J Antibiot; 1982 Feb; 35(2):438-59. PubMed ID: 6953260
[TBL] [Abstract][Full Text] [Related]
9. [In vivo antibacterial activity of cefbuperazone. Synergy of cefbuperazone for bactericidal effect with human polymorphonuclear leukocytes].
Kumasaka Y; Nakahata H; Hirai Y; Imamura K; Takebe K; Suzuki I; Senda H
Jpn J Antibiot; 1986 Jan; 39(1):154-8. PubMed ID: 3517405
[TBL] [Abstract][Full Text] [Related]
10. In-vitro susceptibility and in-vivo efficacy of antimicrobials in the treatment of intraabdominal sepsis in mice.
Brook I; Gillmore JD
J Antimicrob Chemother; 1993 Mar; 31(3):393-401. PubMed ID: 8486573
[TBL] [Abstract][Full Text] [Related]
11. [Update on antibiotic therapy. 19) Cefotetan].
Di Nola F
Minerva Med; 1983 Nov; 74(43):2653-8. PubMed ID: 6379515
[No Abstract] [Full Text] [Related]
12. In vitro susceptibility and in vivo efficacy of antimicrobials in the treatment of Bacteroides fragilis-Escherichia coli infection in mice.
Brook I
J Infect Dis; 1989 Oct; 160(4):651-6. PubMed ID: 2677161
[TBL] [Abstract][Full Text] [Related]
13. Comparison of cefoxitin, cefotetan, and ampicillin/sulbactam as prophylaxis for polymicrobial infection in mice.
Brook I
Clin Infect Dis; 1995 Jun; 20 Suppl 2():S376-7. PubMed ID: 7548603
[No Abstract] [Full Text] [Related]
14. Role of cephamycins in obstetrics and gynecology.
Sweet RL
J Reprod Med; 1990 Nov; 35(11 Suppl):1064-9. PubMed ID: 2277374
[TBL] [Abstract][Full Text] [Related]
15. [Determination of the MIC of cefotetan against freshly isolated gram-negative bacilli].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukushima Y; Fukayama S; Nishimura Y; Oda S; Tanaka S; Sato K
Jpn J Antibiot; 1989 Nov; 42(11):2363-76. PubMed ID: 2621779
[TBL] [Abstract][Full Text] [Related]
16. Exudate levels and bactericidal activity of cefazolin in a new local infection system using rat granuloma pouches.
Nishida M; Murakawa T
Antimicrob Agents Chemother; 1977 Jun; 11(6):1042-8. PubMed ID: 879750
[TBL] [Abstract][Full Text] [Related]
17. [Antibacterial activity of MT-141 against anaerobic bacteria].
Watanabe T; Hara T; Kasai T; Ishii T; Miyauchi K; Date H; Jinzaki M; Shindo H; Matsugami A; Goi H
Jpn J Antibiot; 1984 Jun; 37(6):1058-69. PubMed ID: 6092738
[TBL] [Abstract][Full Text] [Related]
18. Antibacterial activity of the cephamycin cefotetan: an in-vitro comparison with other beta-lactam antibiotics.
Clarke AM; Zemcov SJ
J Antimicrob Chemother; 1983 Jan; 11 Suppl():67-72. PubMed ID: 6404881
[TBL] [Abstract][Full Text] [Related]
19. Comparative bactericidal and morphological effects of five cephamycins on cells of three gram-negative bacilli at decreasing drug concentrations.
Goi H; Watanabe T; Miyauchi K; Kazuno Y; Inouye S
Drugs Exp Clin Res; 1985; 11(11):771-80. PubMed ID: 3915467
[TBL] [Abstract][Full Text] [Related]
20. Significance of inducible cephalosporinase remaining in the experimentally infected rat granuloma pouch after beta-lactam therapy.
Araki H; Minami S; Watanabe Y; Yasuda T
Antimicrob Agents Chemother; 1991 Jun; 35(6):1131-6. PubMed ID: 1929254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
